Henry Schein (NASDAQ:HSIC) Upgraded by Citigroup to Strong-Buy Rating

Henry Schein (NASDAQ:HSIC) was upgraded by equities research analysts at Citigroup to a “strong-buy” rating in a research note issued on Wednesday, MarketBeat Ratings reports. The firm presently has a $100.00 price target on the stock. Citigroup’s target price would indicate a potential upside of 29.52% from the company’s previous close.

Several other equities analysts have also weighed in on HSIC. Morgan Stanley upped their price objective on shares of Henry Schein from $58.00 to $61.00 and gave the company an “underweight” rating in a report on Wednesday, February 25th. Leerink Partners reiterated a “market perform” rating on shares of Henry Schein in a report on Monday, March 9th. Mizuho upped their price objective on shares of Henry Schein from $81.00 to $88.00 and gave the company a “neutral” rating in a report on Wednesday, February 25th. JPMorgan Chase & Co. upped their target price on shares of Henry Schein from $78.00 to $92.00 and gave the stock an “overweight” rating in a report on Wednesday, February 25th. Finally, Wells Fargo & Company upped their target price on shares of Henry Schein from $76.00 to $87.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 25th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $86.69.

Henry Schein Price Performance

Shares of NASDAQ HSIC opened at $77.21 on Wednesday. The firm’s 50-day moving average price is $76.93 and its 200-day moving average price is $73.87. Henry Schein has a 1-year low of $61.94 and a 1-year high of $89.29. The firm has a market capitalization of $8.86 billion, a P/E ratio of 23.61, a P/E/G ratio of 2.29 and a beta of 0.88. The company has a current ratio of 1.38, a quick ratio of 0.76 and a debt-to-equity ratio of 0.59.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, February 24th. The company reported $1.34 earnings per share for the quarter, beating the consensus estimate of $1.30 by $0.04. Henry Schein had a net margin of 3.02% and a return on equity of 15.16%. The firm had revenue of $3.44 billion for the quarter, compared to analyst estimates of $3.34 billion. During the same quarter in the prior year, the business earned $1.19 earnings per share. The business’s quarterly revenue was up 7.7% compared to the same quarter last year. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. Equities research analysts anticipate that Henry Schein will post 4.74 earnings per share for the current fiscal year.

Insider Transactions at Henry Schein

In other Henry Schein news, Director Kurt P. Kuehn sold 2,844 shares of the stock in a transaction dated Tuesday, March 10th. The shares were sold at an average price of $78.96, for a total value of $224,562.24. Following the completion of the sale, the director owned 15,420 shares in the company, valued at approximately $1,217,563.20. This trade represents a 15.57% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Stanley M. Bergman sold 43,812 shares of the stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $81.31, for a total transaction of $3,562,353.72. Following the completion of the sale, the chief executive officer owned 383,803 shares of the company’s stock, valued at approximately $31,207,021.93. This trade represents a 10.25% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 105,911 shares of company stock worth $8,574,982. Company insiders own 1.08% of the company’s stock.

Institutional Investors Weigh In On Henry Schein

A number of hedge funds have recently modified their holdings of the stock. CYBER HORNET ETFs LLC purchased a new position in Henry Schein in the 2nd quarter valued at approximately $25,000. MUFG Securities EMEA plc purchased a new position in Henry Schein in the 2nd quarter valued at approximately $27,000. Flagship Harbor Advisors LLC bought a new position in Henry Schein in the 4th quarter valued at $30,000. Federated Hermes Inc. bought a new position in Henry Schein in the 4th quarter valued at $32,000. Finally, Los Angeles Capital Management LLC bought a new position in Henry Schein in the 4th quarter valued at $37,000. Institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.